3 ms·
Yeah, a company would certainly turn down a $10B a year drug because revenues declined after a few years! Sure it’s not as successful as Lipitor (pretty much t
by refurb 7y ago
Yeah, a company would certainly turn down a $10B a year drug because revenues declined after a few years!
Sure it’s not as successful as Lipitor (pretty much the most successful drug ever), but it’s total sales DWARF 95% of the drugs out there.